List of Tables:
Table 1. Snapshot of North America Monoclonal Antibodies Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in North America Monoclonal Antibodies Market 32
Table 5. North America Monoclonal Antibodies Market by Source, 2019-2030, $ bn 40
Table 6. North America Monoclonal Antibodies Market by Category, 2019-2030, $ bn 46
Table 7. North America Monoclonal Antibodies Market by Production Type, 2019-2030, $ bn 50
Table 8. North America Monoclonal Antibodies Market by Application, 2019-2030, $ bn 54
Table 9. North America Monoclonal Antibodies Market: Cancer Therapy by Type, 2019-2030, $ bn 57
Table 10. North America Monoclonal Antibodies Market by End User, 2019-2030, $ bn 67
Table 11. North America Monoclonal Antibodies Market by Country, 2019-2030, $ bn 73
Table 12. U.S. Monoclonal Antibodies Market by Source, 2019-2030, $ bn 77
Table 13. U.S. Monoclonal Antibodies Market by Application, 2019-2030, $ bn 77
Table 14. U.S. Monoclonal Antibodies Market by End User, 2019-2030, $ bn 77
Table 15. Canada Monoclonal Antibodies Market by Source, 2019-2030, $ bn 79
Table 16. Canada Monoclonal Antibodies Market by Application, 2019-2030, $ bn 79
Table 17. Canada Monoclonal Antibodies Market by End User, 2019-2030, $ bn 79
Table 18. Mexico Monoclonal Antibodies Market by Source, 2019-2030, $ bn 81
Table 19. Mexico Monoclonal Antibodies Market by Application, 2019-2030, $ bn 81
Table 20. Mexico Monoclonal Antibodies Market by End User, 2019-2030, $ bn 81
Table 21. Abbott Laboratories: Company Snapshot 86
Table 22. Abbott Laboratories: Business Segmentation 86
Table 23. Abbott Laboratories: Product Portfolio 87
Table 24. Abbott Laboratories: Revenue, 2018-2020, $ bn 87
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Monoclonal Antibodies Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Monoclonal Antibodies Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Monoclonal Antibodies Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porters Fiver Forces Analysis of North America Monoclonal Antibodies Market 36
Figure 12. Breakdown of North America Monoclonal Antibodies Market by Source, 2019-2030, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2021-2030 by Source, Value ($ bn) and Share (%) 41
Figure 14. North America Monoclonal Antibodies Market by Source: Human, 2019-2030, $ bn 42
Figure 15. North America Monoclonal Antibodies Market by Source: Humanized, 2019-2030, $ bn 43
Figure 16. North America Monoclonal Antibodies Market by Source: Chimeric, 2019-2030, $ bn 44
Figure 17. North America Monoclonal Antibodies Market by Source: Murine, 2019-2030, $ bn 45
Figure 18. Breakdown of North America Monoclonal Antibodies Market by Category, 2019-2030, % of Sales Revenue 47
Figure 19. North America Addressable Market Cap in 2021-2030 by Category, Value ($ bn) and Share (%) 47
Figure 20. North America Monoclonal Antibodies Market by Category: Branded mAbs, 2019-2030, $ bn 48
Figure 21. North America Monoclonal Antibodies Market by Category: Biosimilar mAbs, 2019-2030, $ bn 49
Figure 22. Breakdown of North America Monoclonal Antibodies Market by Production Type, 2019-2030, % of Sales Revenue 51
Figure 23. North America Addressable Market Cap in 2021-2030 by Production Type, Value ($ bn) and Share (%) 51
Figure 24. North America Monoclonal Antibodies Market by Production Type: In Vitro Production, 2019-2030, $ bn 52
Figure 25. North America Monoclonal Antibodies Market by Production Type: In Vivo Production, 2019-2030, $ bn 53
Figure 26. Breakdown of North America Monoclonal Antibodies Market by Application, 2019-2030, % of Revenue 55
Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 55
Figure 28. North America Monoclonal Antibodies Market by Application: Cancer, 2019-2030, $ bn 56
Figure 29. North America Monoclonal Antibodies Market by Cancer Type: Breast Cancer, 2019-2030, $ bn 58
Figure 30. North America Monoclonal Antibodies Market by Cancer Type: Colorectal Cancer, 2019-2030, $ bn 59
Figure 31. North America Monoclonal Antibodies Market by Cancer Type: Lung Cancer, 2019-2030, $ bn 60
Figure 32. North America Monoclonal Antibodies Market by Cancer Type: Ovarian Cancer, 2019-2030, $ bn 61
Figure 33. North America Monoclonal Antibodies Market by Cancer Type: Other Cancer Types, 2019-2030, $ bn 62
Figure 34. North America Monoclonal Antibodies Market by Application: Autoimmune Diseases, 2019-2030, $ bn 63
Figure 35. North America Monoclonal Antibodies Market by Application: Inflammatory Diseases, 2019-2030, $ bn 64
Figure 36. North America Monoclonal Antibodies Market by Application: Infectious Diseases, 2019-2030, $ bn 65
Figure 37. North America Monoclonal Antibodies Market by Application: Other Applications, 2019-2030, $ bn 66
Figure 38. Breakdown of North America Monoclonal Antibodies Market by End User, 2019-2030, % of Revenue 68
Figure 39. North America Addressable Market Cap in 2021-2030 by End User, Value ($ bn) and Share (%) 68
Figure 40. North America Monoclonal Antibodies Market by End User: Hospitals, 2019-2030, $ bn 69
Figure 41. North America Monoclonal Antibodies Market by End User: Research Institutes, 2019-2030, $ bn 70
Figure 42. North America Monoclonal Antibodies Market by End User: Other End Users, 2019-2030, $ bn 71
Figure 43. Breakdown of North America Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue 73
Figure 44. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 74
Figure 45. U.S. Monoclonal Antibodies Market, 2019-2030, $ bn 76
Figure 46. Canada Monoclonal Antibodies Market, 2019-2030, $ bn 78
Figure 47. Monoclonal Antibodies Market in Mexico, 2019-2030, $ bn 80
Figure 48. Growth Stage of North America Monoclonal Antibodies Industry over the Forecast Period 82
